Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia

Journal of Infection and Chemotherapy

Volumn 15, Issue 5, 2009, Pages 343-346

  Kim, Tark ^a   Kim, Sung Han ^a   Park, Ki Ho ^a   Cho, Oh Hyun ^a   Sung, Heungsup ^b   Kim, Mi Na ^b   Choi, Sang Ho ^a   Jeong, Jin Yong ^a   Woo, Jun Hee ^a   Kim, Yang Soo ^a   Lee, Sang Oh ^a  

^a Asan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Clindamycin; Pentamidine; Pneumocystis jirovecii; Pneumonia; Primaquine

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; PENTAMIDINE; PREDNISOLONE; PRIMAQUINE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 70350496049     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0710-z     Document Type: Article

References (10)

1. C.F. Thomas Jr A.H. Limper 2004 Pneumocystis pneumonia N Engl J Med 350 2487 2498 10.1056/NEJMra032588 1:CAS:528:DC%2BD2cXkvVGnsr0%3D 15190141 (Pubitemid 38736546)
2. N.C. Klein F.P. Duncanson T.H. Lenox C. Forszpaniak C.B. Sherer H. Quentzel, et al. 1992 Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial AIDS 6 301 305 1:STN:280:DyaK383jt1Wmtw%3D%3D 1567574
3. T. Benfield C. Atzori R.F. Miller J. Helweg-Larsen 2008 Second-line salvage treatment of aids-associated Pneumocystis jirovecii pneumonia: a case series and systematic review J Acquir Immune Defic Syndr 48 63 67 10.1097/QAI.0b013e31816de84d 18360286 (Pubitemid 351600861)
4. J.G. O'Brien B.J. Dong R.L. Coleman L. Gee K.B. Balano 1997 A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia Clin Infect Dis 24 854 859 9142782
5. E. Toma S. Fournier M. Poisson R. Morisset D. Phaneuf C. Vega 1989 Clindamycin with primaquine for Pneumocystis carinii pneumonia Lancet I 1046 1048 10.1016/S0140-6736(89)92446-X
6. G.A. Noskin R.L. Murphy J.R. Black J.P. Phair 1992 Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia Clin Infect Dis 14 183 188 1:STN:280:DyaK383jvFGltA%3D%3D 1571426
7. A. Humar M. Michaels 2006 AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation Am J Transplant 6 262 274 10.1111/j.1600-6143.2005.01207.x 1:STN:280:DC%2BD28%2FjvVCjug%3D%3D 16426310 (Pubitemid 43382161)
8. R.A. Smego Jr S. Nagar B. Maloba M. Popara 2001 A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia Arch Intern Med 161 1529 1533 10.1001/archinte.161.12.1529 1:CAS:528:DC%2BD3MXltFehtro%3D 11427101
9. J.F. Murray C.P. Felton S.M. Garay M.S. Gottlieb P.C. Hopewell D.E. Stover, et al. 1984 Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop N Engl J Med 310 1682 1688 1:STN:280:DyaL2c3hvFKisA%3D%3D 6328301
10. L.S. Efferen D. Nadarajah D.S. Palat 1989 Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a different perspective Am J Med 87 401 404 1:STN:280:DyaK3c%2FitlGhtw%3D%3D 2801731